Regorafenib (BAY 73-4506)
A10250-25
25mg
Brand
AdooQ BioScience
Description
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an orally bioavailable multikinase inhibitor targeting both the tumor and its vasculature.
|
In vitro (25°C) |
DMSO |
97 mg/mL (200.9 mM) |
|
|
Water |
<1 mg/mL (<1 mM) |
|
|
Ethanol |
<1 mg/mL (<1 mM) |
|
In vivo |
30% PEG400/0.5% Tween80/5% propylene glycol |
30 mg/mL |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|
|
|
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
|
0.1 mM |
20.71 mL |
103.56 mL |
207.13 mL |
|
0.5 mM |
4.14 mL |
20.71 mL |
41.43 mL |
|
1 mM |
2.07 mL |
10.36 mL |
20.71 mL |
|
5 mM |
0.41 mL |
2.07 mL |
4.14 mL |
*The above data is based on the productmolecular weight 482.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|
CATALOG NUM |
A10250 |
|
ACTIONS |
Inhibitor |
|
M. WT |
482.8 |
|
FORMULA |
C21H15ClF4N4O3 |
|
SOLUBILITY |
DMSO |
|
PURITY |
>98% |
|
STORAGE |
at -20°C 3 years Powder |
|
CAS NO. |
755037-03-7 |
|
SMILES |
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F |
Application
Reactivity
